SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000920465-14-000120
Filing Date
2014-11-12
Accepted
2014-11-12 16:03:32
Documents
9
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ljpc-2014930x10q.htm 10-Q 499550
2 EXHIBIT ljpc-2014930xexhibit311.htm EX-31.1 14689
3 EXHIBIT ljpc-2014930xexhibit321.htm EX-32.1 8895
  Complete submission text file 0000920465-14-000120.txt   2583930

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ljpc-20140930.xml EX-101.INS 299254
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ljpc-20140930.xsd EX-101.SCH 17399
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ljpc-20140930_cal.xml EX-101.CAL 25133
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ljpc-20140930_def.xml EX-101.DEF 94724
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ljpc-20140930_lab.xml EX-101.LAB 258117
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ljpc-20140930_pre.xml EX-101.PRE 141749
Mailing Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122
Business Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36282 | Film No.: 141213924
SIC: 2836 Biological Products, (No Diagnostic Substances)